UK Metered Dose Inhaler Market Size, Share and Forecast 2019-2025

Posted by OMR Global on February 20th, 2020

UK metered dose inhaler market is anticipated to grow at a substantial rate of around 2.5% during the forecast period. The metered dose inhalers find a significant role to treat respiratory diseases including asthma, bronchitis, emphysema, and COPD. As the prevalence of asthma and other respiratory diseases increases across UK, the demand for metered dose inhaler is also expected to increase for treatment purposes. As per the International Monetary Fund GDP of the country was .9 trillion in 2017. UK comprises England, Scotland, Wales and Northern Ireland. The total population of the country in 2017 was 65 million, out of which about 18% are of the geriatric population. Mortalities related to asthma and COPD are high in UK and due to these a significant investment by the government and people can be forecast in the near future. 

A full Report of UK Metered Dose Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/uk-metered-dose-inhaler-market 

UK metered dose inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators metered dose inhaler are analyzed. The preventive inhaler segment led the global metered dose inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. 

UK Metered Dose Inhaler Market Segmentation 

By Type 

  •          Preventive Inhaler
  •          Reliever Inhaler
  •          Long Acting Bronchodilators Inhaler 

By Application 

  •          Asthma
  •          Chronic Obstructive Pulmonary Disease (COPD) 

By End-User 

  •          Homecare
  •          Hospitals and Clinics 

Company Profiles 

  •          3M Co.
  •          Acorda Therapeutics, Inc.
  •          Adamis Pharmaceuticals Corp.
  •          Adherium Ltd.
  •          AstraZeneca PLC
  •          Bespak
  •          Boehringer Ingelheim International GmbH
  •          Chiesi Farmaceutici S.P.A.
  •          GF Health
  •          GlaxoSmithKline PLC
  •          H&T Presspart Manufacturing Ltd.
  •          Koninklijke Philips N.V.
  •          Novartis AG
  •          Omron Healthcare Inc.
  •          ResMed Corp.
  •          Pulmatrix Inc.
  •          Savara, Inc.
  •          Teicos Pharma Ltd.
  •          Teva Pharmaceuticals Industries Ltd.
  •          Vitalograph Ltd. 

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. AnuragTiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 780-304-0404

Like it? Share it!


OMR Global

About the Author

OMR Global
Joined: November 12th, 2019
Articles Posted: 203

More by this author